Our genomes are filled with errors that were once impossible to correct. But in CRISPR, we finally found an extraordinarily ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Want a disease-free life or a baby with blue eyes? CRISPR might be mankind's gene editing Get Out of Jail Free card, and it's on its way.

CRISPR Therapeutics analysis: long-term upside despite volatility. Track Casgevy ramp, pipeline milestones & cash runway.

Genetic disorders occur due to alterations in the primary genetic material—deoxyribonucleic acid (DNA)—of an organism.

Innovative research into the gene-editing tool targets influenza’s ability to replicate—stopping it in its tracks.

Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and ...

Scribe expects to initiate a first-in-human hypercholesterolemia study in mid-2026 with STX-1150, its lead cardiometabolic assetSTX-1150 is designed to deliver durable therapeutic LDL-C lowering with ...

The need to change regulations around gene-editing treatments was endorsed in November by the head of the US Food and Drug ...

A live webcast of the presentation will be available on the "Events & Presentations" page in the Investors section of the ...

Picture CRISPR-Cas9, a gene editing technology, as a GPS-guided scalpel: gRNA directs the Cas9 enzyme, a protein that cuts ...

CRISPR Therapeutics AG (CRSP) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...